Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nan Ni

Showing results (101-110 of 103) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 103 results.
Scientific Reports|March 10, 2022
Optical coherence tomography and imaging biomarkers as outcome predictors in diabetic macular edema treated with dexamethasone implantHung-Da Chou, Cheng-Hsiu Wu, Wei-Yu Chiang, et al.
Journal of Liposome Research|August 8, 2020
Multifunctional osthole liposomes and brain targeting functionality with potential applications in a mouse model of Alzheimer's diseaseYing-Nan Ni, Liang Kong, Xue-Tao Li, et al.
Human Vaccines & Immunotherapeutics|December 19, 2023
Safety and immunogenicity of primary vaccination with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: Two randomized, observer-blinded, placebo-controlled and dose-escalation phase 1 clinical trialsGui-Ling Chen, Yuan-Zheng Qiu, Kai-Qi Wu, et al.
Pageof 11

Showing results (101-110 of 103) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 103 results.
Scientific Reports|March 10, 2022
Optical coherence tomography and imaging biomarkers as outcome predictors in diabetic macular edema treated with dexamethasone implantHung-Da Chou, Cheng-Hsiu Wu, Wei-Yu Chiang, et al.
Journal of Liposome Research|August 8, 2020
Multifunctional osthole liposomes and brain targeting functionality with potential applications in a mouse model of Alzheimer's diseaseYing-Nan Ni, Liang Kong, Xue-Tao Li, et al.
Human Vaccines & Immunotherapeutics|December 19, 2023
Safety and immunogenicity of primary vaccination with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: Two randomized, observer-blinded, placebo-controlled and dose-escalation phase 1 clinical trialsGui-Ling Chen, Yuan-Zheng Qiu, Kai-Qi Wu, et al.
Pageof 11